Design and Optimization of Novel Hydroxamate-Based Histone Deacetylase Inhibitors of Bis-Substituted Aromatic Amides Bearing Potent Activities against Tumor Growth and Metastasis
摘要:
Histone deacetylases (HDACs) are one of the most promising drug targets for cancer therapy, and since more than 90% of all cancer-related deaths are associated with tumor metastasis, developing strategies to inhibit tumor metastasis while retaining anti-tumor growth activity are of great interest. Herein we demonstrated the design and identification of a series of novel hydroxamate-based HDAC inhibitors bearing potent activities against tumor growth and metastasis. Optimization of the initial hit resulted in the discovery of new HDAC inhibitors through studying the structureactivity relationship. Among them, compound 11b, one of the most potent leads, exhibited nanomolar IC50 values toward inhibition of class I and IIb HDACs as well as sub-micromolar activity against proliferation and migration of breast cancer cells in vitro. More importantly, it also significantly suppressed tumor growth in a breast tumor xenograft mouse model and dose-dependently blocked in vivo tumor metastasis in a mouse pulmonary metastasis model.
Design and Optimization of Novel Hydroxamate-Based Histone Deacetylase Inhibitors of Bis-Substituted Aromatic Amides Bearing Potent Activities against Tumor Growth and Metastasis
Histone deacetylases (HDACs) are one of the most promising drug targets for cancer therapy, and since more than 90% of all cancer-related deaths are associated with tumor metastasis, developing strategies to inhibit tumor metastasis while retaining anti-tumor growth activity are of great interest. Herein we demonstrated the design and identification of a series of novel hydroxamate-based HDAC inhibitors bearing potent activities against tumor growth and metastasis. Optimization of the initial hit resulted in the discovery of new HDAC inhibitors through studying the structureactivity relationship. Among them, compound 11b, one of the most potent leads, exhibited nanomolar IC50 values toward inhibition of class I and IIb HDACs as well as sub-micromolar activity against proliferation and migration of breast cancer cells in vitro. More importantly, it also significantly suppressed tumor growth in a breast tumor xenograft mouse model and dose-dependently blocked in vivo tumor metastasis in a mouse pulmonary metastasis model.
Oxo/imido heterometathesis of N-sulfinylamines and carbonyl compounds catalyzed by silica-supported vanadium oxochloride
作者:Pavel A. Zhizhko、Anton A. Zhizhin、Dmitry N. Zarubin、Nikolai A. Ustynyuk、Dmitry A. Lemenovskii、Boris N. Shelimov、Leonid M. Kustov、Olga P. Tkachenko、Gayane A. Kirakosyan
DOI:10.1016/j.jcat.2011.07.011
日期:2011.10
with a higher vanadium content are contaminated with a significant amount of d1 vanadium species. The silica-supported vanadium complexes act as heterogeneous catalysts for oxo/imido heterometathesis between N-sulfinylamines and carbonyl compounds affording imines and SO2. Grafting VOCl3 onto silica leads to a dramatic enhancement of its catalytic activity. A novel water-free express method for preparation
通过无水接枝VOCl 3到二氧化硅表面上,制备了一系列二氧化硅负载的钒氧杂配合物。获得的材料已通过拉曼,漫反射FTIR(DRIFT)和UV-vis,51 V固态NMR和X射线光电子能谱,元素分析和N 2物理吸附进行了表征。发现低钒含量(1-5%)的样品主要由分离的四面体d 0单元(SiO)V(O)Cl 2组成,而钒含量较高的材料则被显着污染。 d 1的量钒物种。二氧化硅负载的钒络合物充当N-亚磺酰基胺与提供亚胺和SO 2的羰基化合物之间的羰基/亚胺基异位复分解反应的非均相催化剂。将VOCl 3接枝到二氧化硅上可大大提高其催化活性。已开发出一种新型的无水表达方法,用于制备多种醛和某些酮的亚胺。值得注意的是,这是过渡金属介导的酮的异复酰亚胺化的第一个例子。